You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NAPROXEN SOD ER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NAPROXEN SOD ER

Average Pharmacy Cost for NAPROXEN SOD ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 9.02124 EACH 2025-01-22
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 9.16443 EACH 2024-12-18
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 9.23469 EACH 2024-11-20
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 8.02005 EACH 2024-08-21
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 8.55838 EACH 2024-07-17
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 8.55838 EACH 2024-06-19
NAPROXEN SOD ER 500 MG TABLET 00480-0952-58 8.55838 EACH 2024-05-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Naproxen Sodium

Introduction to Naproxen Sodium

Naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID), is widely used for its analgesic, anti-inflammatory, and antipyretic properties. It is available in various formulations, including oral tablets and liquid suspension, and is marketed by major pharmaceutical companies such as Bayer AG and Roche.

Market Drivers

The naproxen sodium market is driven by several key factors:

Availability and Profiling

The availability of naproxen sodium as both a prescription and over-the-counter (OTC) drug significantly boosts its market. The well-established profiling of its benefits and risks also contributes to its widespread use[1].

Increasing Prevalence of Arthritis and Other Pain-Related Disorders

The growing incidence of arthritis and other musculoskeletal disorders drives the demand for effective analgesics and anti-inflammatory medications. For instance, it is projected that around 1 in 4 adults in the U.S. have been diagnosed with arthritis, which is more common in women than men[4].

Geriatric Population Growth

The increase in the geriatric population, who are more prone to conditions such as osteoarthritis and rheumatoid arthritis, further propels the market for naproxen sodium[1].

Market Segmentation

The naproxen sodium market is segmented based on several criteria:

Disease Indication

The market is segmented into various disease indications including osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, juvenile arthritis, bursitis, menstrual cramps, gout, and tendonitis[1].

Formulation

Naproxen sodium is available in oral tablets and liquid suspension formulations[1].

Distribution Channel

The market is classified into hospital pharmacies, retail pharmacies, drug stores, and e-commerce channels[1].

Region

The market is segmented into Asia Pacific (APAC), Europe, Middle East & Africa (MEA), North America (NA), and Latin America (LA)[1].

Price Trends and Projections

Global Price Dynamics

The price of naproxen sodium is influenced by several global factors:

  • North America: The market experienced a steady upward trajectory in prices due to supply constraints, elevated production costs, and geopolitical factors. Supply chain disruptions and natural disasters also contributed to price increases[2].
  • Europe: The European market, particularly in Germany, displayed robust pricing trends driven by seasonal demand and supply chain disruptions linked to geopolitical tensions[2][5].
  • Asia-Pacific: The region saw a notable upward pricing trajectory, especially in China, driven by strong demand from both domestic and international markets[5].

Current Prices

As of Q2 2024, the prices of naproxen sodium were:

  • USA: $35,550 USD/MT
  • Europe: $36,850 USD/MT
  • China: $36,121 USD/MT[2][5].

Forecast

The price trend for naproxen sodium is expected to be volatile due to ongoing global supply chain uncertainties, geopolitical shifts, and escalating production costs. The market is likely to experience continued price increases driven by robust demand and supply constraints[2][5].

Challenges and Restraints

Despite the growth drivers, the naproxen sodium market faces several challenges:

Side Effects

Adverse reactions to NSAID use, including stomach pain, allergic reactions, stomach ulcers, and dizziness, are significant restraints. GI bleeding associated with NSAIDs is a common reason for emergency hospital admissions[4].

Competition from Other Drugs

The availability of other drugs with lower risks of abdominal ulcers or allergic reactions compared to naproxen sodium also hampers the market. Competition from steroids and other NSAIDs used in pain reduction for arthritis is a notable restraint[1].

Regulatory Considerations

The use of naproxen sodium during late pregnancy is advised against due to the risk of premature closing of the ductus arteriosus, which can necessitate early delivery. This adds to the regulatory complexities and restraints[1].

Key Players

Major players in the naproxen sodium market include:

  • Bayer AG: Markets Aleve and Midol Extended Relief as OTC drugs.
  • Roche: Markets Naprosyn and Anaprox as prescription brands.
  • Other Players: Pfizer Inc, Reckitt Benckiser Group PLC, Novartis AG, and several Indian pharmaceutical companies like Zydus Group and Lupin[1][4].

Market Size and Growth

The global oral nonsteroidal anti-inflammatory drugs market, which includes naproxen sodium, was valued at USD 20,697.05 million in 2022 and is expected to grow to USD 32,641.01 billion by 2030, with a CAGR of around 5.86% during the forecast period of 2023-2030[4].

Conclusion

The naproxen sodium market is driven by its widespread availability, the increasing prevalence of arthritis and other pain-related disorders, and the growing geriatric population. However, it faces challenges such as adverse side effects, competition from other drugs, and regulatory considerations. The price trend is expected to remain volatile due to global supply chain uncertainties and escalating production costs.

Key Takeaways

  • Market Drivers: Availability as OTC and prescription drug, increasing prevalence of arthritis, and growth in the geriatric population.
  • Market Segmentation: Disease indication, formulation, distribution channel, and region.
  • Price Trends: Volatile due to supply chain disruptions, production costs, and geopolitical factors.
  • Challenges: Side effects, competition from other drugs, and regulatory considerations.
  • Key Players: Bayer AG, Roche, Pfizer Inc, and several other pharmaceutical companies.

Frequently Asked Questions (FAQs)

1. What are the primary uses of naproxen sodium? Naproxen sodium is used for its analgesic, anti-inflammatory, and antipyretic properties, treating conditions such as arthritis, muscle strain, back pain, knee pain, and menstrual cramps.

2. Who are the major players in the naproxen sodium market? Major players include Bayer AG, Roche, Pfizer Inc, Reckitt Benckiser Group PLC, and several Indian pharmaceutical companies like Zydus Group and Lupin.

3. What are the key drivers of the naproxen sodium market? The market is driven by its availability as both OTC and prescription drugs, the increasing prevalence of arthritis and other pain-related disorders, and the growth in the geriatric population.

4. What are the significant challenges facing the naproxen sodium market? Challenges include adverse side effects, competition from other drugs with lower risks, and regulatory considerations such as its use during late pregnancy.

5. What is the expected growth rate of the oral nonsteroidal anti-inflammatory drugs market? The market is expected to grow with a CAGR of around 5.86% during the forecast period of 2023-2030.

Cited Sources

  1. Transparency Market Research - Naproxen Market Insight and Trends 2024
  2. Procurement Resource - Naproxen Sodium Price Trend and Forecast
  3. FDA - Estimating Cost Savings from New Generic Drug Approvals in 2018
  4. Data Bridge Market Research - Global Oral Nonsteroidal Anti Inflammatory Drugs Market
  5. OpenPR - Naproxen Sodium Prices, Chart, News, Demand and Forecast

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.